Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| CMH09804-003 | Other Grant/Funding Number | Chi Mei Medical Center, Taiwan |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Stellate ganglion block (SGB) has been the alternative treatment of Meniere's disease for years. However, objective evidence of the effect of SGB was still lack. The investigators conducted a randomized controlled study to examine the immediate effects of SGB in SP/AP of electrocochleography (ECoG).
Ten patients were randomly assigned to receive stellate ganglion block. These ten patients made up the experimental group. Another ten patients in the control group were assigned to receiving one dosage of oral medications: 0.25mg of erispan@ (fludiazine) , 25mg cephadol@ (diphenidol), and 200mg kentons@ (tocopherol nicotinate).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Stellate ganglion block | Experimental | treated with SGB |
|
| Oral medication | Active Comparator | treated with oral medications: 0.25mg of erispan@ (fludiazine) , 25mg cephadol@ (diphenidol), and 200mg kentons@ (tocopherol nicotinate). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| stellate ganglion block | Procedure | stellate ganglion block |
| |
| Measure | Description | Time Frame |
|---|---|---|
| SP/AP of Electrocochleography | SP/AP of ECoG was recorded 2 hours after SGB. to be compared with the SP/AP of ECoG recorded before treatment | ECoG was reorded 2 hours after SGB |
| Measure | Description | Time Frame |
|---|---|---|
| SP/AP recorded at 4 hours after SGB | SP/AP recorded at 4 hours after SGB was compared with that of pretreatment with SGB | 4 hours after SGB |
| SP/AP recorded at 6 hours after SGB | SP/AP recorded at 4 hours after SGB was compared with the SP/AP recorded before SGB |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yung-Song Lin, M.D. | Chi Mei Medical Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| i Mei Medical Center Tainan, Taiwan, Taiwan | Tainan | Tainan | 70014 | Taiwan |
Not provided
| ID | Term |
|---|---|
| D014717 | Vertigo |
| D008575 | Meniere Disease |
| D034381 | Hearing Loss |
| ID | Term |
|---|---|
| D015837 | Vestibular Diseases |
| D007759 | Labyrinth Diseases |
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C004858 | diphenidol |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 0.25mg, fludiazine |
| Drug |
0.25mg of erispan@ (fludiazine), p.o. one dose only. |
|
|
| 25mg cephadol@ (diphenidol) | Drug | 25mg cephadol@ (diphenidol) p.o. one dose only. |
|
| 200mg kentons@ (tocopherol nicotinate). | Drug | 200mg kentons@ (tocopherol nicotinate) p.o. one dose only. |
|
| 6 hours after SGB |
| scores of verbal scale for vertigo recorded at 6 hours after SGB | scores of verbal scale for vertigo recorded at 6 hours after SGB was compared to the scores recorded before SGB | 6 hours after SGB |
| D009461 |
| Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D018159 | Endolymphatic Hydrops |
| D006311 | Hearing Disorders |
| D012678 | Sensation Disorders |